Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-01-15, Stock:LLY, The news for the past five days is as follows:
2019-01-08: NEWS1: Eli Lilly giving price info on advertised drugs via website.NEWS2: Eli Lilly giving price info on advertised drugs via website.NEWS3: Why Eli Lilly Is Buying Loxo Oncology for $8 Billion.NEWS4: WEISSLAW LLP: Loxo Oncology, Inc. Acquisition May Not Be In The Best Interests of LOXO Shareholders.NEWS5: Crowded Cancer Space Triggers Big M&A Deals: More in Store?.NEWS6: Crowded Cancer Space Triggers Big M&A Deals: More in Store?.NEWS7: Lilly Offers $8B to Acquire Cancer-Focused Small Biotech Loxo.NEWS8: Lilly Offers $8B to Acquire Cancer-Focused Small Biotech Loxo.NEWS9: Eli Lilly (LLY) is a Great Momentum Stock: Should You Buy?.NEWS10: Eli Lilly (LLY) is a Great Momentum Stock: Should You Buy?.NEWS11: Loxo Oncology Is Expected to Boost Eli Lilly’s Revenue in 2019.NEWS12: Eli Lilly to cut 250 jobs at France plant, through voluntary redundancy.NEWS13: Eli Lilly to cut 250 jobs at France plant, through voluntary redundancy.NEWS14: Company News For Jan 8, 2019.NEWS15: Company News For Jan 8, 2019.NEWS16: Is Eli Lilly Overpaying for Loxo Oncology?.NEWS17: Is Eli Lilly Overpaying for Loxo Oncology?.NEWS18: Pfizer or Eli Lilly: Which Company Is More Cost Efficient?.NEWS19: Eli Lilly (LLY) is a Great Momentum Stock: Should You Buy?.NEWS20: What Are Analysts Recommending for Eli Lilly and Loxo Oncology?.NEWS21: Lilly Offers $8B to Acquire Cancer-Focused Small Biotech Loxo.NEWS22: Crowded Cancer Space Triggers Big M&A Deals: More in Store?.NEWS23: 4 Biotechs That Are Potential Buyouts Post Celgene Deal.NEWS24: 4 Biotechs That Are Potential Buyouts Post Celgene Deal.NEWS25: Company News For Jan 8, 2019.NEWS26: Pfizer or Eli Lilly: Which Company Has Better Margins?.NEWS27: 4 Biotechs That Are Potential Buyouts Post Celgene Deal.NEWS28: Is Eli Lilly Overpaying for Loxo Oncology?.NEWS29: Eli Lilly Is Set to Acquire Loxo Oncology.NEWS30: Two ways to play the biotech boom.NEWS31: Pfizer or Eli Lilly: Whose Earnings Are Seeing Better Growth?.NEWS32: Debt Buybacks Could Be The New Stock Buybacks.NEWS33: Deal-making in the global health-care sector is set to rebound in 2019, law firm says.NEWS34: Asian shares mixed amid silence on China-US trade talks.NEWS35: Asian shares mixed amid silence on China-US trade talks.NEWS36: [$$] Eli Lilly to Buy Loxo Oncology in $8 Billion Deal.NEWS37: Lilly makes $8 billion bet on drugs for rare cancers with Loxo Oncology buy.NEWS38: So Long, Loxo.NEWS39: So Long, Loxo.NEWS40: Gilead, Pfizer Execs Suggest Even More Pharma M&A Is on Way.NEWS41: PRESS DIGEST- Financial Times - Jan 8.NEWS42: [$$] Good News for Biotech: Shoppers Unfazed by Selloff.NEWS43: Eli Lilly (LLY) Gains But Lags Market: What You Should Know.NEWS44: Eli Lilly (LLY) Gains But Lags Market: What You Should Know.NEWS45: 5 Must-See Stock Charts for Tuesday, Including Roku.NEWS46: 5 Must-See Stock Charts for Tuesday, Including Roku.NEWS47: Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Loxo Oncology, Inc. (LOXO) on Behalf of Stockholders and Encourages LOXO Investors to Contact the Firm.NEWS48: Jim Cramer: These Pharma Deals Are Game Changers.
2019-01-09: NEWS1: CNBC'S CHRISTINA FARR & ANGELICA LAVITO: JP MORGAN'S DIMON HOSTED A DINNER FOR PHARMA EXECUTIVES, AND A MAJOR TOPIC WAS AMAZON.NEWS2: JP Morgan's Dimon hosted a dinner for pharma executives, and a major topic was Amazon.NEWS3: MERGER ALERT – BDMS, LOXO and MB: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies.NEWS4: Novartis' Crizanlizumab Gets Breakthrough Therapy Status.NEWS5: Novartis' Crizanlizumab Gets Breakthrough Therapy Status.NEWS6: The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Lilly and Glaxo.NEWS7: The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Lilly and Glaxo.NEWS8: The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Lilly and Glaxo.NEWS9: Novartis' Crizanlizumab Gets Breakthrough Therapy Status.NEWS10: Does Eli Lilly&apos;s $8 Billion Splurge Make Array BioPharma a Buy Now?.NEWS11: See what the IHS Markit Score report has to say about Eli Lilly and Co..NEWS12: Eli Lilly and Loxo: A Robust Oncology Pipeline for Future Years.NEWS13: Pfizer or Eli Lilly: Which Company Has the Better Dividend Policy?.NEWS14: Report: Exploring Fundamental Drivers Behind Virtusa, Eli Lilly, Cree, NewJersey Resources, Getty Realty, and PennantPark Investment — New Horizons, Emerging Trends, and Upcoming Developments.NEWS15: A Pension Fund Bought Apple Stock at the Wrong Time.NEWS16: Why Eli Lilly Is Buying Loxo Oncology for $8 Billion.NEWS17: Why Eli Lilly Is Buying Loxo Oncology for $8 Billion.NEWS18: Would-Be Dealmakers Warn of M&A, IPO Delays Due to Shutdown.
2019-01-10: NEWS1: 3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year.NEWS2: 3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year.NEWS3: Will Pfizer Join The Buying Spree With This Small Biotech Stock?.NEWS4: 3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year.NEWS5: 3 Defensive ETFs to Protect Yourself From Another Market Selloff.NEWS6: Big Pharma CEOs Indicate More M&A Deals at JP Morgan Meeting.NEWS7: Big Pharma CEOs Indicate More M&A Deals at JP Morgan Meeting.NEWS8: Big Pharma CEOs Indicate More M&A Deals at JP Morgan Meeting.NEWS9: [$$] Big Pharma’s Cancer Race.
2019-01-11: NEWS1: 5 Reasons Why Investors Should Buy Novo Nordisk (NVO) in 2019.NEWS2: Stock Market Rally Runs Into Resistance; Boeing, GM, Macy's, American Airlines: Weekly Review.NEWS3: Lilly eyes more cancer deals, but wary of CAR-T, gene therapy.NEWS4: 7 Pharmaceutical Stocks That Just Raised Prices This Year.NEWS5: The Loxo Oncology Purchase Eventually Could Help Eli Lilly Stock.NEWS6: The Loxo Oncology Purchase Eventually Could Help Eli Lilly Stock.NEWS7: Why Aratana Therapeutics Inc. Is Tumbling Today.NEWS8: Why Aratana Therapeutics Inc. Is Tumbling Today.NEWS9: Puma Biotech (PBYI) Down More Than 40% in 90 Days: Here's Why.NEWS10: Puma Biotech (PBYI) Down More Than 40% in 90 Days: Here's Why.NEWS11: Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet.NEWS12: Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet.NEWS13: iShares Edge MSCI USA Momentum Factor ETF Experiences Big Outflow.NEWS14: iShares Edge MSCI USA Momentum Factor ETF Experiences Big Outflow.NEWS15: Puma Biotech (PBYI) Down More Than 40% in 90 Days: Here's Why.NEWS16: Biotech stocks are off to the best start of the year since 2012 on heels of J.P. Morgan conference.NEWS17: Biotech stocks are off to the best start of the year since 2012 on heels of J.P. Morgan conference.NEWS18: The Loxo Oncology Purchase Eventually Could Help Eli Lilly Stock.NEWS19: Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet.NEWS20: The 3 Best-Performing Biotech Stocks at the J.P. Morgan Healthcare Conference.NEWS21: The 3 Best-Performing Biotech Stocks at the J.P. Morgan Healthcare Conference.NEWS22: The 3 Best-Performing Biotech Stocks at the J.P. Morgan Healthcare Conference.NEWS23: 4 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2019.
2019-01-14: NEWS1: Eli Lilly CEO Predicts 2019 Will Be Big Year for Biotech Acquisitions.NEWS2: Eli Lilly (LLY) Dips More Than Broader Markets: What You Should Know.NEWS3: Will Biogen Jump On This Biotech Stock Amid Buying Spree?.NEWS4: House Democrats launch drug-pricing probe into a dozen major health-care companies.NEWS5: Here's Why Eli Lilly Stock Surged 37% in 2018.NEWS6: Here's Why Eli Lilly Stock Surged 37% in 2018.

Answer: Rise